Covid-19
-
Crispr technology is used against new coronavirus
Stanford University scientists are actively exploring whether gene editing technology can be used to fight epidemics, but so far, they have only solved a small part of the mystery.
-
New coronavirus: detailed explanation of asymptomatic infections
Recently, people with asymptomatic infection with the new coronavirus pneumonia have attracted widespread attention, and many people may even get nervous.
-
Protective coating made of new materials may kill new coronavirus
At present, masks that protect doctors and nurses from new coronavirus infections can only play a protective role, but researchers from the University of Florida are developing a protective coating, which includes a new mask material, which can be used in several Stop and kill the virus in seconds.
-
World's first new coronavirus vaccine starts Phase II clinical trial
China-based CanSino Biologics announced on April 9 that its recombinant new coronavirus vaccine (adenoviral vector) is planning to conduct a phase II clinical trial in China in the near future based on preliminary safety data from the phase I clinical trial.
-
Chinese scholar develops rapid detection system for coronavirus nucleic acid
A team led by researcher Wang Daming of Suzhou Institute of Biomedical Engineering Technology, Chinese Academy of Sciences has recently developed a new rapid detection system for coronavirus nucleic acid.
-
New antiviral drug provides hope in fight against coronavirus
A new drug called EIDD-2801 is expected to change the way doctors treat new coronary pneumonia. The drug can reduce lung damage in animal tests and is about to enter human clinical trials.
-
Coronavirus can survive on masks for up to 7 days, study says
Recently, the US Centers for Disease Control and Prevention (CDC) changed its view on the use of masks during the COVID-19 pandemic.
-
China expected to be 1st smartphone market to recover from Covid-19
China is expected to become the world's first smartphone market to recover from the impact of a new coronavirus epidemic, a new report said today.
-
First coronavirus DNA vaccine candidate to enter clinical trials
On April 7, Inovio Pharmaceuticals announced that the US Food and Drug Administration (FDA) has accepted the company's application for a new drug clinical trial (IND) for the new coronavirus candidate DNA vaccine INO-4800.
-
Chinese EV maker Lixiang's CEO: Covid-19 has far more impact than SARS
The impact of the new coronavirus epidemic on the economy and consumer fields has far exceeded SARS, and even exceeded the impact of the 2008 financial crisis on the global economy, Li Xiang, CEO of Chinese electric vehicle maker Li Auto said on Weibo today.